Integrated bioinformatic approach of Balur therapy for breast cancer subtypes
Balur is a topical complementary alternative medicine that can be applied to breast cancer. Balur eliminates free radicals and heavy metals which it found enhance in cancer patients compared with healthy persons. Balur uses materials that potentially can halt cancer progression and development such...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
EDP Sciences
2025-01-01
|
Series: | BIO Web of Conferences |
Online Access: | https://www.bio-conferences.org/articles/bioconf/pdf/2025/05/bioconf_icgrc2025_02008.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832539699242074112 |
---|---|
author | Aristyani Sherry Subagjo Saraswati Rahayu Tintrim Sumitro Sutiman B. |
author_facet | Aristyani Sherry Subagjo Saraswati Rahayu Tintrim Sumitro Sutiman B. |
author_sort | Aristyani Sherry |
collection | DOAJ |
description | Balur is a topical complementary alternative medicine that can be applied to breast cancer. Balur eliminates free radicals and heavy metals which it found enhance in cancer patients compared with healthy persons. Balur uses materials that potentially can halt cancer progression and development such as aspirin, coffee, moringa, and tobacco. This study was to describe the complexity of Balur in the biological system of breast cancer subtypes such as luminal A, liminal B, and HER-2, which had been found in high numbers in Indonesia, with an integrative bioinformatic approach. Active compounds found from literature studies were collected and screened by skin permeability variables. For breast cancer subtypes, differential expressed gene (DEG) identification was used to explore the target of Balur compounds. The Cytoscape software was used to construct the network of Balur compounds and target proteins of breast cancer subtypes. Gene Ontology, pathway, docking, hub gene, and survival analysis were applied to investigate the detailed mechanism of Balur to breast cancer in each subtype. The results showed that Balur compounds targeted respectively 68, 86, and 84 genes of luminal A, luminal B, and HER-2. From these target genes, 7 Balur compounds had higher binding energy than chemotherapy compounds when they docked with hub genes from each subtype. In conclusion, this study explained the pharmacological mechanisms of Balur therapy, which has great potential as a complementary therapy for breast cancer subtypes. |
format | Article |
id | doaj-art-93e4b9828b604d2f806f9d7ce56a1aca |
institution | Kabale University |
issn | 2117-4458 |
language | English |
publishDate | 2025-01-01 |
publisher | EDP Sciences |
record_format | Article |
series | BIO Web of Conferences |
spelling | doaj-art-93e4b9828b604d2f806f9d7ce56a1aca2025-02-05T10:43:07ZengEDP SciencesBIO Web of Conferences2117-44582025-01-011540200810.1051/bioconf/202515402008bioconf_icgrc2025_02008Integrated bioinformatic approach of Balur therapy for breast cancer subtypesAristyani Sherry0Subagjo Saraswati1Rahayu Tintrim2Sumitro Sutiman B.3Lembaga Penelitian Peluruhan Radikal BebasLembaga Penelitian Peluruhan Radikal BebasLembaga Penelitian Peluruhan Radikal BebasLembaga Penelitian Peluruhan Radikal BebasBalur is a topical complementary alternative medicine that can be applied to breast cancer. Balur eliminates free radicals and heavy metals which it found enhance in cancer patients compared with healthy persons. Balur uses materials that potentially can halt cancer progression and development such as aspirin, coffee, moringa, and tobacco. This study was to describe the complexity of Balur in the biological system of breast cancer subtypes such as luminal A, liminal B, and HER-2, which had been found in high numbers in Indonesia, with an integrative bioinformatic approach. Active compounds found from literature studies were collected and screened by skin permeability variables. For breast cancer subtypes, differential expressed gene (DEG) identification was used to explore the target of Balur compounds. The Cytoscape software was used to construct the network of Balur compounds and target proteins of breast cancer subtypes. Gene Ontology, pathway, docking, hub gene, and survival analysis were applied to investigate the detailed mechanism of Balur to breast cancer in each subtype. The results showed that Balur compounds targeted respectively 68, 86, and 84 genes of luminal A, luminal B, and HER-2. From these target genes, 7 Balur compounds had higher binding energy than chemotherapy compounds when they docked with hub genes from each subtype. In conclusion, this study explained the pharmacological mechanisms of Balur therapy, which has great potential as a complementary therapy for breast cancer subtypes.https://www.bio-conferences.org/articles/bioconf/pdf/2025/05/bioconf_icgrc2025_02008.pdf |
spellingShingle | Aristyani Sherry Subagjo Saraswati Rahayu Tintrim Sumitro Sutiman B. Integrated bioinformatic approach of Balur therapy for breast cancer subtypes BIO Web of Conferences |
title | Integrated bioinformatic approach of Balur therapy for breast cancer subtypes |
title_full | Integrated bioinformatic approach of Balur therapy for breast cancer subtypes |
title_fullStr | Integrated bioinformatic approach of Balur therapy for breast cancer subtypes |
title_full_unstemmed | Integrated bioinformatic approach of Balur therapy for breast cancer subtypes |
title_short | Integrated bioinformatic approach of Balur therapy for breast cancer subtypes |
title_sort | integrated bioinformatic approach of balur therapy for breast cancer subtypes |
url | https://www.bio-conferences.org/articles/bioconf/pdf/2025/05/bioconf_icgrc2025_02008.pdf |
work_keys_str_mv | AT aristyanisherry integratedbioinformaticapproachofbalurtherapyforbreastcancersubtypes AT subagjosaraswati integratedbioinformaticapproachofbalurtherapyforbreastcancersubtypes AT rahayutintrim integratedbioinformaticapproachofbalurtherapyforbreastcancersubtypes AT sumitrosutimanb integratedbioinformaticapproachofbalurtherapyforbreastcancersubtypes |